Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 26, 2017
Pharmacy Choice - News - Front Page Healthcare News - May 26, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/26/17 - "A Therapeutic Protocol for Treating Ovarian Cancer" in Patent Application Approval Process (USPTO 20170119727)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Kremmidiotis, Gabriel; BIBBY, David C.; RISCHIN, Danny, filed on May 30, 2014, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Bionomics
5/26/17 - "Extended-Release Topiramate Capsules" in Patent Application Approval Process (USPTO 20170119808)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors BETTERMAN, Sarah Michelle; TANTRY, Jaidev Srinivas; PATRICK, Laura Marie, filed on November 21, 2016, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is
5/26/17 - "SELF-EMULSIFYING COMPOSITION OF W3 FATTY ACID" in Patent Application Approval Process (USPTO 20170119724)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors FUJII, Hirosato; YAMAGATA, Motoo, filed on January 18, 2017, was made available online on May 11, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Mochida Pharmaceutical Co.,
5/26/17 - 2:18 PM To: SCHUMER-PRESS@LISTS.SENATE.GOV
"Nearly two million veteransthat's one in 10 rely on Medicaid for their health care. The Republican plan to dismantle the Affordable Care Act cuts more than $800 billion from Medicaid. At best, this would significantly scale back our veterans' Medicaid benefits and, at worst, cause them to lose their benefits altogether. "
5/26/17 - Abbott Labs: A genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases
It currently markets seven U.S. Food and Drug Administration or foreign cleared or approved clinical products in addition to distributing over 300 Analyte Specific Reagent and research products through its direct sales operations in the United States and Europe and a worldwide distribution network covering 59 countries. Mary Szela joined Melinta...
5/26/17 - Abeona Therapeutics receives FDA orphan designation for gene therapy
The FDA has granted Orphan Drug Designation for Abeona Therapeutics's EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa...
5/26/17 - Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa [Tehran Times (Iran)]
Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced today that the FDA has granted Orphan Drug Designation for Abeonas EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa, including recessive dystrophic...
5/26/17 - Active Pharmaceutical Ingredients Market Outlook and Worldwide Forecast to 2027
Global Active Pharmaceutical Ingredients Information, by types, by applications, by manufacturing method-Forecast 2027 Pune, India 05/26/2017 Market Synopsis of Active pharmaceutical ingredients Market:. Active Pharmaceutical Ingredient is the integral part of the drug because of which the disease gets cured. Request a Sample Report@...
5/26/17 - AERI Is Awesome, GWPH Abuzz, FDA Panel Nod For PBYI [Sport360]
Today`s Daily Dose brings you news about Aerie Pharma`s positive efficacy results from phase III study of its glaucoma drug candidate Roclatan; Alnylam`s public offering and FDA panel`s support for approval of Puma`s breast cancer drug Neratinib. Shares of Aerie Pharmaceuticals Inc. climbed more than 27% in extended trading on Wednesday, following.
5/26/17 - Agency Information Collection Activities: Proposed Collection; Comment Request; Applications for Food and Drug Administration Approval To Market a...
SUMMARY: The Food and Drug Administration is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed...
5/26/17 - American Discount Pharmacy Corp./ UPS: Has been featured on Fox and Wink TV for having some of the best prices on FDA-approved and USA Wholesaler medications
American Discount Pharmacy Corp./ UPS. American Discount Pharmacy has been featured on Fox and Wink TV for having some of the best prices on FDA- approved and USA Wholesaler medications. Their is a prototype UPS located within the store of American Discount Pharmacy Corp./ UPS and we are proud to be a part of this unique combination.
5/26/17 - APA Issues Statement on Congressional Budget Office's Score
The American Psychological Association issued the following statement by President Antonio E. Puente in response to the Congressional Budget Office's scoring of the American Health Care Act:. The new Congressional Budget Office score of the bill the House passed weeks ago confirms that this health care reform legislation is in reality not reform.
5/26/17 - Apellis Receives EMA Orphan Drug Designation for APL-2 in PNH
By a News Reporter-Staff News Editor at Drug Week Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on inhibition of the complement system, announced that the European Medicines Agency has granted orphan medicinal product designation to APL-2, a complement C3 inhibitor, in the treatment of patients with paroxysmal.
5/26/17 - Applications for 2017 DeviceLab Biomedical Engineering Scholarship Now Being Accepted
Deadline for $1000 Bioengineering Scholarship is August 15, 2017
5/26/17 - Araim Pharmaceuticals' Cibinetide ARA 290 Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of...
Araim Pharmaceuticals' Cibinetide ARA 290 Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis. By a News Reporter-Staff News Editor at Health& Medicine Week Araim Pharmaceuticals Inc., announced the publication of Phase 2 b study results in small fiber neuropathy of the Company's lead com
5/26/17 - Arc Issues Statement on AHCA Being Devastating to Medicaid
The Arc of the United States issued the following statement by Senior Executive Officer Marty Ford in response to the Congressional Budget Office's report on the House-passed American Health Care Act:. Now we know, and our worst fears are confirmed- 14 million fewer people enrolled in Medicaid by 2026, and $834 billion in spending cuts to Medicaid
5/26/17 - AstraZeneca delivers new data on expanding portfolio of cancer medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Release date- 26052017- AstraZeneca, along with its global biologics research and development arm, MedImmune, will demonstrate how it is rapidly delivering on the Company's science-led strategy for transformational cancer medicine development at the 2017 American Society of Clinical Oncology Annual Meeting in Chicago, US, 2-6 June 2017.
5/26/17 - Autism study questions and answers [The San Diego Union-Tribune]
May 26 This question and answer article about the autism clinical trial led by Robert Naviaux, professor of genetics in the departments of medicine, pediatrics and pathology of the University of California San Diego, was provided by the university. It describes the rationale for using the old sleeping sickness drug suramin and implications if the
5/26/17 - Autism symptoms improve in small clinical trial of century-old drug [The San Diego Union-Tribune]
May 26 Autism symptoms improved in five boys given a century-old drug for sleeping sickness, according to a new study led by University of California San Diego researchers. The small clinical trial involved 10 boys, including five who received a placebo and did not show improvement. The gains lasted for several weeks, said Robert Naviaux, a UC Sa
5/26/17 - Autism symptoms of five boys improve in early trial of century-old drug [The San Diego Union-Tribune]
May 26 Autism symptoms improved in five boys given a century-old drug for sleeping sickness, according to a new study led by University of California San Diego researchers. The small clinical trial involved 10 boys, including five who received a placebo and did not show improvement. The gains lasted for several weeks, said Robert Naviaux, a UC Sa
5/26/17 - Avastin as effective as Eylea for treating central retinal vein occlusion
By a News Reporter-Staff News Editor at Health& Medicine Week Monthly eye injections of Avastin are as effective as the more expensive drug Eylea for the treatment of central retinal vein occlusion, according to a clinical trial funded by the National Eye Institute, part of the National Institutes of Health. "This head-to-head comparison of two
5/26/17 - Bankruptcy Filings
21st Century Oncology Holdings Chapter 11 Petition Filed 21st Century Oncology Holdings and more than 50 affiliated Debtors filed for Chapter 11 protection with the U.S. Bankruptcy Court in the Southern District of New York, lead case number 17-22770. The Company, which operates cancer treatment centers, is represented by Christopher Marcus of Ki
5/26/17 - BIO Applauds Creation of FDA Opioid Policy Steering Committee
Release date- 24052017- Washington, DC- Biotechnology Innovation Organization President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug Administration:. Washington, DC- Biotechnology Innovation Organization President and CEO Jim Greenwood issued the...
5/26/17 - BioPharma Services, Inc. Successfully Completes 3 FDA Inspections with ZERO Form 483's
BioPharma Services, Inc. is proud to announce that it has successfully completed 3 inspections this month by the US FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri. Over the course of 2 weeks, the back-to-back inspections focused on a total of 9 studies including 4 bioanalytical validations that were
5/26/17 - Bioreactor Market to surpass $1.9bn by 2024: Global Market Insights, Inc. [Daily News Egypt]
-Bioreactor Market size is set to exceed USD 1.9 billion by 2024; according to a new research report by Global Market Insights, Inc. Rising chronic disease prevalence and growing research in the field of biopharmaceuticals will drive the global bioreactor market size. Increased focus of biopharmaceutical companies to develop effective treatment opt
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415